DOACs Qualitative Study v.1.0

  • Research type

    Research Study

  • Full title

    Understanding the factors influencing participation in a clinical study of direct oral anticoagulants (DOACs) among breastfeeding women:a qualitative study

  • IRAS ID

    218089

  • Contact name

    Yating Zhao

  • Contact email

    yating.zhao@kcl.ac.uk

  • Sponsor organisation

    King's College London

  • Duration of Study in the UK

    0 years, 3 months, 13 days

  • Research summary

    Venous thromboembolism (VTE) is the formation of blood clots in human's body. It has a relatively increased incidence in women following the birth of a baby. So mothers identified at significant risk of VTE or diagnosed with VTE are prescribed 'blood thinning'medications - anticoagulants. In recent year, new anticoagulants have become available. These new anticoagulants are called DOACs. They have many advantages over traditional anticoagulants which require women to inject, and/or attend clinic for blood monitoring. However, it is not known whether these DOACs transfer into breast milk.
    We are designing a clinical trial to provide valuable information on the use of these DOACs in breastfeeding women. It will be a major challenge to recruit breastfeeding women as they are special population who are generally excluded from clinical trials. Prior to finalising our proposed clinical trial, we will conduct this focus group study to elicit information regarding their consenting issues, concerns and expectations to the proposed clinical trial, with the aim of improving the recruitment strategies and the management of our proposed clinical trial(DOACs Excretion into Breast Milk).
    This focus group study will consist of 3 sub-groups (4-5 participants in each group). All participants are women who have had breastfeeding experience within the past 5 years or who are breastfeeding currently. Participants will be asked to discuss their opinions with an open-ended question guide focusing on perceptions and concerns related to clinical trials and our proposed clinical trial . All conversations in the focus group will be audio-taped. Each focus group will last approximately 1 hour, and will be conducted in King's College Hospital.

  • REC name

    South West - Cornwall & Plymouth Research Ethics Committee

  • REC reference

    17/SW/0015

  • Date of REC Opinion

    25 Jan 2017

  • REC opinion

    Further Information Favourable Opinion